胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場- 世界の産業規模、シェア、動向、機会、予測、剤形別、地域別、競合別、2020～2030年

胃内滞留型ドラッグデリバリーシステムのアウトソーシングの世界市場規模は2024年に13億7,000万米ドルで、予測期間中のCAGRは5.51%で2030年には18億9,000万米ドルに達すると予測されています。

世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場は、製薬・ヘルスケア業界の中でもダイナミックで急速に発展している分野です。胃内滞留型ドラッグデリバリーシステムとは、薬剤を長期間胃内に滞留させ、放出制御と標的治療効果を促進する特殊な製剤と技術を指します。この市場セグメントは、薬物のバイオアベイラビリティを高め、患者のコンプライアンスを改善し、副作用を軽減する新規ドラッグデリバリーシステムに対する需要の増加により、著しい成長を遂げています。

消化器疾患のような慢性疾患の増加により、効果的で患者に優しいドラッグデリバリーソリューションが必要とされています。さらに、人口の高齢化と先進的な医薬品技術に対する意識の高まりが、胃内滞留型ドラッグデリバリーシステムに対する需要を後押ししています。製薬業界では、専門知識を活用し、市場投入までの時間を短縮するため、これらのシステムの開発・製造を専門の受託研究機関（CRO）や受託製造機関（CMO）に委託するケースが増えています。

この市場の特徴は、製剤開発、前臨床試験、臨床試験、胃内滞留型ドラッグデリバリーシステムの商業規模での製造など、多様なアウトソーシングサービスにあります。CROとCMOは、研究開発、技術選択、規制遵守、品質保証を包括するエンドツーエンドのソリューションを提供する上で極めて重要な役割を果たしています。その結果、製薬会社は創薬と臨床開発というコアコンピタンスに集中できる一方、胃内滞留型ドラッグデリバリーに関する専門的な知識はアウトソーシングパートナーに頼ることができます。

さらに、地域拡大、戦略的提携、研究開発活動への投資が市場の急成長に寄与しています。浮遊システム、生体接着システム、拡張可能システムなど、新規の胃内滞留型ドラッグデリバリー技術の開発により、市場は技術革新の急増を目の当たりにしています。

主な市場促進要因

消化器疾患の有病率の上昇

主な市場課題

知的財産に関する懸念

主な市場動向

標的ドラッグデリバリー需要の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 剤形別（錠剤、液剤、マイクロスフェア、カプセル剤、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ
  • 剤形別
  • 地域別

第5章 アジア太平洋地域の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Catalent, Inc
• Lonza Group
• Evonik Industries AG
• Colorcon
• Quotient Sciences
• AptarGroup, Inc.
• Aenova Holding GmbH
• Evotec SE
• Vectura Group Ltd
• Ashland Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Gastroretentive Drug Delivery Systems Outsourcing Market was valued at USD 1.37 billion in 2024 and is expected to reach USD 1.89 billion by 2030 with a CAGR of 5.51% during the forecast period. The Global Gastroretentive Drug Delivery Systems Outsourcing Market is a dynamic and rapidly evolving sector within the pharmaceutical and healthcare industry. Gastroretentive drug delivery systems refer to specialized formulations and technologies that enable drugs to be retained in the stomach for an extended period, facilitating controlled release and targeted therapeutic effects. This market segment is witnessing significant growth due to the increasing demand for novel drug delivery systems that enhance drug bioavailability, improve patient compliance, and reduce side effects.

the rising prevalence of chronic diseases, such as gastrointestinal disorders, which require effective and patient-friendly drug delivery solutions. Moreover, an aging population and increasing awareness of advanced pharmaceutical technologies are propelling the demand for gastroretentive drug delivery systems. The pharmaceutical industry is increasingly outsourcing the development and manufacturing of these systems to specialized contract research organizations (CROs) and contract manufacturing organizations (CMOs) to leverage their expertise and reduce time-to-market.

The market is characterized by a diverse range of outsourcing services, including formulation development, preclinical and clinical testing, and commercial-scale production of gastroretentive drug delivery systems. CROs and CMOs are playing a pivotal role in offering end-to-end solutions that encompass research and development, technology selection, regulatory compliance, and quality assurance. As a result, pharmaceutical companies can focus on their core competencies in drug discovery and clinical development, while relying on outsourcing partners for specialized expertise in gastroretentive drug delivery.

Furthermore, regional expansion, strategic collaborations, and investments in research and development activities are contributing to the market's rapid growth. The market is witnessing a surge in innovation, with the development of novel gastroretentive drug delivery technologies, including floating systems, bio adhesive systems, and expandable systems.

Key Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The rising prevalence of gastrointestinal disorders is a pivotal driver behind the growth of the Global Gastroretentive Drug Delivery Systems Outsourcing Market. Gastrointestinal conditions, such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease, and peptic ulcers, are becoming increasingly common worldwide. These disorders can significantly impact an individual's quality of life and managing them effectively often requires specialized pharmaceutical interventions.

According to World Gastroenterology Organisation, overall, 49% of females and 36.6% of males met criteria for at least one FGID - the most common disorders in all regions being functional constipation, functional dyspepsia, proctalgia fugax, functional diarrhea and IBS at prevalence rates of 11.7%, 7.2%, 5.9%, 4.7% and 4.1, respectively.

Gastroretentive drug delivery systems play a crucial role in addressing the challenges associated with treating gastrointestinal disorders. These innovative systems allow drugs to remain in the stomach for an extended period, ensuring localized treatment and controlled release of therapeutic agents. This approach not only enhances the bioavailability of drugs but also minimizes side effects and maximizes the effectiveness of treatment, providing much-needed relief to patients suffering from gastrointestinal ailments.

Key Market Challenges

Intellectual Property Concerns

In the competitive world of pharmaceuticals, companies invest heavily in research and development to create proprietary innovations, including gastroretentive drug delivery technologies. These innovations often form the core of their product portfolio and protecting them through IP rights is essential for maintaining a competitive edge. The fear of losing exclusive rights to these innovations can lead to hesitancy in sharing proprietary information with outsourcing partners, potentially hampering collaboration.

Collaborations between pharmaceutical companies and contract research organizations (CROs) or contract manufacturing organizations (CMOs) require a degree of information exchange. For the successful development and manufacturing of gastroretentive drug delivery systems, there's a need to share critical data, formulation knowledge, and technical expertise. However, striking the right balance between knowledge sharing and IP protection can be challenging. Pharmaceutical companies must carefully manage their IP while ensuring that their outsourcing partners have the necessary information to deliver high-quality products.

Key Market Trends

Increasing Demand for Targeted Drug Delivery

The Global Gastroretentive Drug Delivery Systems Outsourcing Market is experiencing a significant boost due to the increasing demand for targeted drug delivery solutions. This surge in demand is fueled by several factors and represents a key driving force shaping the future of the pharmaceutical outsourcing industry.

One of the most prominent factors driving the increasing demand for targeted drug delivery is the growing recognition of the limitations of traditional drug delivery methods. Conventional oral drug delivery often lacks specificity, with drugs being absorbed throughout the gastrointestinal tract. This can lead to reduced drug bioavailability and increased side effects, making it less than ideal for many therapeutic applications.

gastroretentive drug delivery systems offer a highly effective means of targeting specific regions within the gastrointestinal tract, particularly the stomach. These systems allow drugs to remain in the stomach for an extended duration, ensuring that they are delivered precisely where they are needed. This localized, site-specific approach not only enhances drug bioavailability but also minimizes unwanted side effects, improving the overall therapeutic outcomes for patients.

Key Market Players

• Catalent, Inc
• Lonza Group
• Evonik Industries AG
• Colorcon
• Quotient Sciences
• AptarGroup, Inc.
• Aenova Holding GmbH
• Evotec SE
• Vectura Group Ltd
• Ashland Inc.

Report Scope:

In this report, the Global Gastroretentive Drug Delivery Systems Outsourcing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastroretentive Drug Delivery Systems Outsourcing Market, By Dosage Form:

• Tablets
• Liquid
• Microspheres
• Capsule
• Others

Gastroretentive Drug Delivery Systems Outsourcing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gastroretentive Drug Delivery Systems Outsourcing Market.

Available Customizations:

Global Gastroretentive Drug Delivery Systems Outsourcing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Dosage Form(Tablets, Liquid, Microspheres, Capsule, Others)
  • 4.2.2. By Region
  • 4.2.3. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Dosage Form
  • 4.3.2. By Region

5. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Dosage Form
  • 5.2.2. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Dosage Form
  • 5.3.2. India Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Dosage Form
  • 5.3.3. Australia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Dosage Form
  • 5.3.4. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Dosage Form
  • 5.3.5. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Dosage Form

6. Europe Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Dosage Form
  • 6.2.2. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Dosage Form
  • 6.3.2. Germany Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Dosage Form
  • 6.3.3. Spain Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Dosage Form
  • 6.3.4. Italy Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Dosage Form
  • 6.3.5. United Kingdom Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Dosage Form

7. North America Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Dosage Form
  • 7.2.2. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Dosage Form
  • 7.3.2. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Dosage Form
  • 7.3.3. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Dosage Form

8. South America Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Dosage Form
  • 8.2.2. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Dosage Form
  • 8.3.2. Argentina Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Dosage Form
  • 8.3.3. Colombia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Dosage Form

9. Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Dosage Form
  • 9.2.2. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Dosage Form
  • 9.3.2. Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Dosage Form
  • 9.3.3. UAE Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Dosage Form

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Gastroretentive Drug Delivery Systems Outsourcing Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Catalent, Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Lonza Group
• 14.3. Evonik Industries AG
• 14.4. Colorcon
• 14.5. Quotient Sciences
• 14.6. AptarGroup, Inc.
• 14.7. Aenova Holding GmbH
• 14.8. Evotec SE
• 14.9. Vectura Group Ltd
• 14.10.Ashland Inc.

15. Strategic Recommendations

16. About Us & Disclaimer